Oxalate disrupts monocyte and macrophage cellular function via Interleukin-10 and mitochondrial reactive oxygen

Parveen Kumar1, Emma Laurence1, David K Crossman2

  • 1Department of Urology, University of Alabama at Birmingham, Birmingham, AL, USA.

Redox Biology
|October 8, 2023
PubMed

Insights

High oxalate intake impairs immune cell function by disrupting mitochondrial and lysosomal pathways. Supplementation with Interleukin-10 (IL-10) or Mitoquinone (MitoQ) can reverse these negative effects, offering potential therapeutic avenues for kidney stone prevention.

Area of Science:

  • Immunology
  • Nephrology
  • Cell Biology

Background:

  • Oxalate, found in plant foods, is a key component of calcium oxalate (CaOx) kidney stones.
  • Dietary oxalate increases urinary crystal formation risk.
  • Previous studies showed oxalate load causes nanocrystalluria and reduces monocyte bioenergetics.

Purpose of the Study:

  • To investigate oxalate-mediated mechanisms in monocytes and macrophages.
  • To identify specific molecular pathways affected by oxalate exposure.

Main Methods:

  • RNA-sequencing on monocytes from subjects after high oxalate load.
  • In-vitro exposure of monocytes and macrophages to oxalate.
  • Analysis of Interleukin-10 (IL-10) and reactive oxygen species (ROS) signaling.
  • Assessment of mitochondrial and lysosomal function, and autophagy.

Main Results:

  • Oxalate altered 1,198 genes, impacting IL-10 signaling, mitochondrial function, and autophagy.
  • In-vitro oxalate exposure induced oxidative stress, decreased IL-10, impaired mitochondrial/lysosomal function, and hindered autophagy.
  • Exogenous IL-10 and MitoQ (Mitoquinone) reversed oxalate-induced cellular dysfunction.

Conclusions:

  • Oxalate impairs monocyte and macrophage metabolism and immune response via IL-10 and ROS signaling.
  • Mitochondrial dysfunction and impaired autophagy are key mechanisms.
  • IL-10 and MitoQ show potential for limiting or reversing oxalate's detrimental effects on immune cells.